Crossmark

Selection of three miRNA signatures with prognostic value in non-M3 acute myeloid leukemia

Crossref DOI link: https://doi.org/10.1186/s12885-019-5315-z

Published Online: 2019-01-30

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xue, Yao

Ge, Yuqiu

Kang, Meiyun

Wu, Cong

Wang, Yaping

Rong, Liucheng

Fang, Yongjun http://orcid.org/0000-0002-6170-6950
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81602913, 81670155)

Natural Science Foundation of Jiangsu Province (BK20150085)

Nanjing Medical Science and Technology Development Project (YKK15140)

Nanjing Medical Science and Technology Development Foundation (QRX17164)

Nanjing Science and Technology Development Foundation (201503043)

Technology Development Foundation of Nanjing Medical University (2014NJMUZD079)
License Information

Text and Data Mining valid from 2019-01-30
More Information

Article History

Received: 22 October 2018

Accepted: 24 January 2019

First Online: 30 January 2019

Ethics approval and consent to participate

: The study was approved by the Ethics Committee of Children’s Hospital of Nanjing Medical University and conformed to the provisions of the Declaration of Helsinki. Data of our present study was downloaded from an open database TCGA, so there was no informed consent from participants.

: Not applicable.

: The authors have no conflict of interest to report.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.